First-Line Lenvatinib plus Pembrolizumab for Hepatocellular Carcinoma: Post hoc Analysis of Japanese Patients from the Phase 3 LEAP-002 Trial
一线使用乐伐替尼联合帕博利珠单抗治疗肝细胞癌:LEAP-002 III期试验中日本患者的事后分析
期刊:Liver Cancer
影响因子:9.1
doi:10.1159/000542572
Kudo, Masatoshi; Ikeda, Masafumi; Aikata, Hiroshi; Numata, Kazushi; Marusawa, Hiroyuki; Hosaka, Tetsuya; Kato, Naoya; Kurosaki, Masayuki; Morimoto, Manabu; Yamashita, Tatsuya; Koga, Hironori; Masaki, Tsutomu; Yatsuzuka, Naoyoshi; Suzuki, Masato; Nagao, Satoshi; Kaneko, Shuichi; Kumada, Hiromitsu